http://www.medicaldaily.com/hepatitis-c-...ial-332128
EXCERPT: According to the World Health Organization, 130 to 150 million people worldwide suffer from chronic infections of Hepatitis C (HCV), a blood borne virus that primarily attacks the liver and can be spread through needle-sharing, contaminated medical equipment, and less often through sexual relations. These sufferers are especially vulnerable to later liver damage, either through cirrhosis or cancer, and 350,000 to 500,000 people die as a result of these diseases every year. While there are available drug treatments for acute Hepatitis C infection and its hardier chronic version, they vary in effectiveness, accessibility, and tolerance, often needing to be received via injection and coming saddled with side effects. Soon enough however, we might be looking at an entirely new playing field, with two studies in this month’s issue of the Journal of the American Medical Association (JAMA) reporting the extraordinary success of an experimental multi-drug oral therapy for chronic HCV infection, even among those who hadn’t responded to previous treatment....
EXCERPT: According to the World Health Organization, 130 to 150 million people worldwide suffer from chronic infections of Hepatitis C (HCV), a blood borne virus that primarily attacks the liver and can be spread through needle-sharing, contaminated medical equipment, and less often through sexual relations. These sufferers are especially vulnerable to later liver damage, either through cirrhosis or cancer, and 350,000 to 500,000 people die as a result of these diseases every year. While there are available drug treatments for acute Hepatitis C infection and its hardier chronic version, they vary in effectiveness, accessibility, and tolerance, often needing to be received via injection and coming saddled with side effects. Soon enough however, we might be looking at an entirely new playing field, with two studies in this month’s issue of the Journal of the American Medical Association (JAMA) reporting the extraordinary success of an experimental multi-drug oral therapy for chronic HCV infection, even among those who hadn’t responded to previous treatment....